Kure It News 

A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), have shown that they can use methylation patterns in cell-free DNA (cfDNA) extracted from blood samples to predict which patients with muscle-invasive bladder cancer are likely to benefit from chemotherapy before their surgery.

Kure It Cancer Research has awarded a $200,000 grant to support the work of Scott Haake, MD, assistant professor of Medicine in the Division of Hematology and Oncology. Haake’s research involves how RNA sequence-based biomarkers can identify targetable biologic drivers of kidney cancer. Kure it Inc. is a nonprofit that funds translational research projects focused on kidney cancer and other underfunded cancers.

A world-renowned physician-scientist in the field of renal cell carcinoma (RCC), W. Kimryn Rathmell, MD, PhD of Vanderbilt University Medical Center, offers to share the impact of two AACR-supported research grants – 2018 AACR-Kure It Research Grant for Immunotherapy in Kidney Cancer and 2010 Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine, on her career and research.

LOS ANGELES (March 31, 2020) - In a new pre-clinical study published this week in the journal Leukemia, the research team of Children's Hospital Los Angeles investigator Hisham Abdel-Azim, MD, MS, worked with colleagues to engineer T-cells to identify and target multiple sites on acute lymphoblastic leukemia cells instead of just one. The early collaboration points the way to future clinical trials to test the therapy.